SUTRO BIOPHARMA, INC. (STRO) Revenue 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$102.5MFY2025 · since FY2016: $59.7M → $102.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102.5M | +65.2% |
| FY2024 | $62.0M | -59.6% |
| FY2023 | $153.7M | +126.8% |
| FY2022 | $67.8M | +9.5% |
| FY2021 | $61.9M | +44.8% |
| FY2020 | $42.7M | -0.0% |
| FY2019 | $42.7M | +11.2% |
| FY2018 | $38.4M | -25.7% |
| FY2017 | $51.7M | -13.4% |
| FY2016 | $59.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice